Annual CFI
-$97.82 M
+$26.89 M+21.56%
December 31, 2023
Summary
- As of February 8, 2025, COGT annual cash flow from investing activities is -$97.82 million, with the most recent change of +$26.89 million (+21.56%) on December 31, 2023.
- During the last 3 years, COGT annual CFI has fallen by -$106.24 million (-1261.81%).
- COGT annual CFI is now -522.40% below its all-time high of $23.16 million, reached on December 31, 2019.
Performance
COGT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$60.19 M
+$144.81 M+171.12%
September 30, 2024
Summary
- As of February 8, 2025, COGT quarterly cash flow from investing activities is $60.19 million, with the most recent change of +$144.81 million (+171.12%) on September 30, 2024.
- Over the past year, COGT quarterly CFI has increased by +$144.81 million (+171.12%).
- COGT quarterly CFI is now at all-time high.
Performance
COGT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$12.91 M
+$150.72 M+92.11%
September 30, 2024
Summary
- As of February 8, 2025, COGT TTM cash flow from investing activities is -$12.91 million, with the most recent change of +$150.72 million (+92.11%) on September 30, 2024.
- Over the past year, COGT TTM CFI has increased by +$150.72 million (+92.11%).
- COGT TTM CFI is now -126.97% below its all-time high of $47.86 million, reached on June 30, 2019.
Performance
COGT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
COGT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.6% | +171.1% | +92.1% |
| 3 y3 years | -1261.8% | +5275.1% | -903.6% |
| 5 y5 years | -828.9% | +100.0% | -6159.1% |
COGT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5590.8% | +21.6% | at high | +139.7% | -650.8% | +92.1% |
| 5 y | 5-year | -522.4% | +21.6% | at high | +139.7% | -155.7% | +92.1% |
| alltime | all time | -522.4% | +21.6% | at high | +139.7% | -127.0% | +92.1% |
Cogent Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $60.19 M(-171.1%) | -$12.91 M(-92.1%) |
| Jun 2024 | - | -$84.63 M(-8205.8%) | -$163.63 M(+4.4%) |
| Mar 2024 | - | $1.04 M(-90.0%) | -$156.66 M(+60.1%) |
| Dec 2023 | -$97.82 M(-21.6%) | $10.49 M(-111.6%) | -$97.82 M(+22.4%) |
| Sep 2023 | - | -$90.54 M(+16.6%) | -$79.90 M(-43.3%) |
| Jun 2023 | - | -$77.66 M(-229.7%) | -$140.91 M(+118.8%) |
| Mar 2023 | - | $59.88 M(+110.8%) | -$64.39 M(-48.4%) |
| Dec 2022 | -$124.72 M(+7155.3%) | $28.41 M(-118.7%) | -$124.72 M(-18.8%) |
| Sep 2022 | - | -$151.54 M(>+9900.0%) | -$153.56 M(+4727.5%) |
| Jun 2022 | - | -$1.14 M(+159.4%) | -$3.18 M(+47.3%) |
| Mar 2022 | - | -$441.00 K(+1.8%) | -$2.16 M(+25.7%) |
| Dec 2021 | -$1.72 M(-120.4%) | -$433.00 K(-62.8%) | -$1.72 M(+33.7%) |
| Sep 2021 | - | -$1.16 M(+845.5%) | -$1.29 M(-115.5%) |
| Jun 2021 | - | -$123.00 K(<-9900.0%) | $8.30 M(-1.5%) |
| Mar 2021 | - | $0.00(0.0%) | $8.42 M(0.0%) |
| Dec 2020 | $8.42 M | $0.00(-100.0%) | $8.42 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $8.42 M(>+9900.0%) | $8.41 M(+3846.9%) |
| Jun 2020 | - | $0.00(-100.0%) | $213.00 K(-99.1%) |
| Dec 2019 | $23.16 M(-319.9%) | -$13.00 K(-105.8%) | $23.16 M(-39.3%) |
| Sep 2019 | - | $226.00 K(-97.2%) | $38.17 M(-20.2%) |
| Jun 2019 | - | $8.00 M(-46.5%) | $47.86 M(-3278.0%) |
| Mar 2019 | - | $14.95 M(-0.3%) | -$1.51 M(-85.7%) |
| Dec 2018 | -$10.53 M(-177.5%) | $15.00 M(+51.3%) | -$10.53 M(-49.0%) |
| Sep 2018 | - | $9.91 M(-124.0%) | -$20.63 M(-16.9%) |
| Jun 2018 | - | -$41.37 M(-798.2%) | -$24.82 M(-222.1%) |
| Mar 2018 | - | $5.92 M(+20.9%) | $20.33 M(+49.6%) |
| Dec 2017 | $13.59 M(-144.7%) | $4.90 M(-14.4%) | $13.59 M(+56.4%) |
| Sep 2017 | - | $5.72 M(+51.3%) | $8.69 M(+193.2%) |
| Jun 2017 | - | $3.78 M(-561.3%) | $2.96 M(-461.3%) |
| Mar 2017 | - | -$820.00 K | -$820.00 K |
| Dec 2016 | -$30.43 M(+836.6%) | - | - |
| Dec 2015 | -$3.25 M | - | - |
FAQ
- What is Cogent Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Cogent Biosciences?
- What is Cogent Biosciences annual CFI year-on-year change?
- What is Cogent Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cogent Biosciences?
- What is Cogent Biosciences quarterly CFI year-on-year change?
- What is Cogent Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cogent Biosciences?
- What is Cogent Biosciences TTM CFI year-on-year change?
What is Cogent Biosciences annual cash flow from investing activities?
The current annual CFI of COGT is -$97.82 M
What is the all time high annual CFI for Cogent Biosciences?
Cogent Biosciences all-time high annual cash flow from investing activities is $23.16 M
What is Cogent Biosciences annual CFI year-on-year change?
Over the past year, COGT annual cash flow from investing activities has changed by +$26.89 M (+21.56%)
What is Cogent Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of COGT is $60.19 M
What is the all time high quarterly CFI for Cogent Biosciences?
Cogent Biosciences all-time high quarterly cash flow from investing activities is $60.19 M
What is Cogent Biosciences quarterly CFI year-on-year change?
Over the past year, COGT quarterly cash flow from investing activities has changed by +$144.81 M (+171.12%)
What is Cogent Biosciences TTM cash flow from investing activities?
The current TTM CFI of COGT is -$12.91 M
What is the all time high TTM CFI for Cogent Biosciences?
Cogent Biosciences all-time high TTM cash flow from investing activities is $47.86 M
What is Cogent Biosciences TTM CFI year-on-year change?
Over the past year, COGT TTM cash flow from investing activities has changed by +$150.72 M (+92.11%)